Product Information
FLAVOXATE HCL 100 MG TABLET is a generic product labeled by PuraCap Laboratories LLC, priced at $0.6943 per EA under NDC 24658072001. Its NADAC has been published 397 times since May 17, 2017.
FDA first approved this application on Nov 30, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
PuraCap Laboratories LLCNDC
24658072001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
FLAVOXATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076835FDA Approved
11/30/2005
TE Code
AB
On Market Since
12/15/2016
Pharmacological Classes
Price Statistics
The NADAC for FLAVOXATE HCL 100 MG TABLET has been published 397 times since May 17, 2017, and over the history we have for it it has risen 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6943 per EA |
|---|---|
| All-time high | $0.9005 (Sep 16, 2020) |
| All-time low | $0.5467 (Aug 23, 2023) |
| Median price | $0.6653 |
| Average price | $0.6751 |
| Largest weekly change | -35.3% (Sep 23, 2020) |
| Weeks tracked | 397 |
| Tracking since | May 17, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+27.0%
5Y
-12.1%
All
+4.3%
Last surveyed Dec 18, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PuraCap Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flavoxate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLAVOXATE HCL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLAVOXATE HCL 100 MG TABLET, manufactured by PuraCap Laboratories LLC, is $0.6943 per EA (NDC 24658072001), effective Dec 18, 2024.
How has the price of FLAVOXATE HCL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLAVOXATE HCL 100 MG TABLET has risen 4.3%. It has been tracked across 397 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for FLAVOXATE HCL 100 MG TABLET?
Since May 17, 2017, the NADAC for FLAVOXATE HCL 100 MG TABLET has ranged from a low of $0.5467 (Aug 23, 2023) to a high of $0.9005 (Sep 16, 2020), with a median of $0.6653 per EA.
Are there cheaper alternatives to FLAVOXATE HCL 100 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLAVOXATE HCL 100 MG TABLET, is $0.3894 per EA — about 44% below FLAVOXATE HCL 100 MG TABLET.
Who manufactures FLAVOXATE HCL 100 MG TABLET?
FLAVOXATE HCL 100 MG TABLET (NDC 24658072001) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.